Compounds > 1h-tetrazole
Page last updated: 2024-08-24

1h-tetrazole and benzofurans

1h-tetrazole has been researched along with benzofurans in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, NJ; Kim, SK; Lee, DW; Lee, SH; Yoo, SE1
Alonso-Galicia, M; Bailey, T; Brochu, RM; de Jesus, RK; Felix, JP; Garcia, ML; Hampton, C; Hernandez, M; Kaczorowski, GJ; Owens, K; Pai, LY; Pasternak, A; Priest, BT; Roy, S; Swensen, AM; Tang, H; Thomas-Fowlkes, B; Walsh, SP; Yan, Y; Yang, L; Zhou, X; Zhu, Y1
Baghel, T; Bhagwati, S; Fatima, S; Gupta, S; Kushwaha, P; Nazir, A; Sashidhara, KV; Siddiqi, MI; Upadhyay, A1

Other Studies

3 other study(ies) available for 1h-tetrazole and benzofurans

ArticleYear
The conformation and activity relationship of benzofuran type of angiotensin II receptor antagonists.
    Bioorganic & medicinal chemistry, 2000, Volume: 8, Issue:9

    Topics: Algorithms; Angiotensin Receptor Antagonists; Benzofurans; Binding, Competitive; Drug Design; Humans; Imidazoles; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Protein Binding; Quantitative Structure-Activity Relationship; Tetrazoles

2000
Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-one.
    Bioorganic & medicinal chemistry letters, 2013, Nov-01, Volume: 23, Issue:21

    Topics: Animals; Benzofurans; Diuresis; Drug Discovery; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Tetrazoles

2013
Synthesis, biological evaluation and molecular dynamic simulations of novel Benzofuran-tetrazole derivatives as potential agents against Alzheimer's disease.
    Bioorganic & medicinal chemistry letters, 2019, 01-01, Volume: 29, Issue:1

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzofurans; Caenorhabditis elegans; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Molecular Dynamics Simulation; Molecular Structure; Protein Aggregates; Structure-Activity Relationship; Tetrazoles

2019